Filing Details

Accession Number:
0001209191-14-032049
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-07 22:34:24
Reporting Period:
2014-05-05
Filing Date:
2014-05-07
Accepted Time:
2014-05-07 21:34:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087432 Intermune Inc ITMN Pharmaceutical Preparations (2834) 943296648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1206199 G Daniel Welch 3280 Bayshore Boulevard
Brisbane CA 94005
Chairman, Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-05 25,000 $8.73 123,106 No 4 M Direct
Common Stock Acquisiton 2014-05-05 3,913 $25.55 127,019 No 4 M Direct
Common Stock Disposition 2014-05-05 28,913 $33.39 98,106 No 4 S Direct
Common Stock Acquisiton 2014-05-06 25,000 $8.73 123,106 No 4 M Direct
Common Stock Acquisiton 2014-05-06 1 $15.34 123,107 No 4 M Direct
Common Stock Acquisiton 2014-05-06 6,518 $15.34 129,625 No 4 M Direct
Common Stock Disposition 2014-05-06 31,519 $36.01 98,106 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Stock Options Common Stock Acquisiton 2014-05-05 25,000 $8.73 25,000 $8.73
Iso Exercise Common Stock Acquisiton 2014-05-05 3,913 $25.55 3,913 $25.55
Stock Options Common Stock Acquisiton 2014-05-06 25,000 $8.73 25,000 $8.73
Iso Exercise Common Stock Acquisiton 2014-05-06 1 $15.34 1 $15.34
Iso Exercise Common Stock Acquisiton 2014-05-06 6,518 $15.34 6,518 $15.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
123,106 2011-12-08 2017-06-08 No 4 M Direct
127,019 2011-05-15 2014-05-15 No 4 M Direct
152,019 2011-12-08 2017-06-08 No 4 M Direct
152,020 2011-12-13 2015-05-13 No 4 M Direct
158,538 2012-05-13 2015-05-13 No 4 M Direct
Footnotes
  1. The transaction was made pursuant to the terms of the 10b5-1 plan in effect at the time of the transaction.
  2. Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $33.00 to $34.17 per share. Full information on the numbers of shares sold at each sale price is available upon request.
  3. Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $36.00 to $36.10 per share. Full information on the numbers of shares sold at each sale price is available upon request.
  4. Fully Exercisable